Scarica l'app Stockscreener
10.01
0.10%
-0.010
Dopo l'orario di chiusura:
10.02
0.010
+0.10%
Precedente Chiudi:
$10.02
Aprire:
$10
Volume 24 ore:
61,306
Relative Volume:
0.80
Capitalizzazione di mercato:
$498.50M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
1,053.68
EPS:
0.0095
Flusso di cassa netto:
-
1 W Prestazione:
-0.40%
1M Prestazione:
-0.69%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$10.00
$10.03
Intervallo di 1 settimana:
$9.675
$10.06
Portata 52W:
$9.675
$10.25
New America Acquisition I Corp Stock (NWAX) Company Profile
Nome
New America Acquisition I Corp
Settore
Industria
Telefono
212-970-5150
Indirizzo
590 MADISON AVENUE, NEW YORK
Compare NWAX vs LION, XXI, MRLN, DMII, UMAC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NWAX
New America Acquisition I Corp
|
10.01 | 498.50M | 0 | 0 | 0 | 0.0095 |
LION
Lionsgate Studios Corp
|
9.63 | 2.79B | 2.80B | -224.60M | -1.10M | -0.8751 |
XXI
Twenty One Capital Inc
|
6.16 | 2.13B | 0 | 4.35M | 456.40K | 0.3397 |
MRLN
Merlin Inc
|
8.27 | 696.85M | 0 | 0 | 0 | 0.00 |
DMII
Drugs Made In America Acquisition Ii Corp
|
9.99 | 655.09M | 0 | 0 | 0 | -0.0028 |
UMAC
Unusual Machines Inc
|
13.60 | 649.91M | 11.20M | -19.19M | -23.24M | -0.7527 |
New America Acquisition I Corp Borsa (NWAX) Ultime notizie
Drugs Made In America Acquisition II Corp. enters $300,000 convertible note agreement - Investing.com
$300K zero‑interest note backs Drugs Made In America II (NASDAQ: DMII) - Stock Titan
New America 10-K: $0.0M Revenue; Net income $0.478M (no EPS disclosed) - TradingView
New America Acquisition I Corp. Reports Earnings Results for the Seven Months Ended December 31, 2025 - MarketScreener
New America Acquisition I (NYSE: NWAX) outlines $345M SPAC structure - Stock Titan
Renatus Tactical Acquisition Corp I (RTAC) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
FGNA.WS (FG New America Acquisition) PB Ratio : (As of Mar. 31, 2026) - GuruFocus
A&O Shearman guides underwriter on TRG Latin America Acquisitions Corp.’s SPAC IPO - A&O Shearman
Drugs Made In America Acquisition Corp. issues $100,000 convertible note as part of $500,000 financing - Investing.com Australia
TRG Latin America's IPO grows to $206.3M after underwriter buys more units - Stock Titan
Complete List of Financial ServicesDiversified Financial ServicesShell Companies Stocks - GuruFocus
14,375,000 Ordinary Shares of Drugs Made In America Acquisition II Corp. are subject to a Lock-Up Agreement Ending on 23-MAR-2026. - marketscreener.com
Stefan Passantino Net Worth (2026) - GuruFocus
Drugs Made In America II (NASDAQ: DMII) plans $1.4M convertible note funding - Stock Titan
Dominari Holdings addresses congressional inquiry on Chinese IPOs - Investing.com
Dominari says IPOs are under 10% of revenue as House panel asks on China - Stock Titan
Boothbay Fund Management LLC Sells 70,000 Shares of Drugs Made In America Acquisition Corp. $DMAA - Defense World
Donald Trump Jr. and Eric Trump back drone company Powerus - qz.com
Clear Street Group Inc. Acquires New Holdings in Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
Radcliffe Capital Management L.P. Has $5.42 Million Position in Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
Trump’s sons back new military drone venture tied to Pentagon work - Moneycontrol.com
Trump sons back launch of new military drone company - Financial Times
$50M KCGI bet, Trump investors behind new U.S. drone merger plan - Stock Titan
Drugs Made In America Acquisition II Corp. confirms trust account balance after review - Investing.com South Africa
[8-K] Drugs Made In America Acquisition II Corp. Reports Material Event | DMII SEC FilingForm 8-K - Stock Titan
Drugs Made In America Acquisition Corp. appoints new CEO after board changes - Investing.com Australia
Drugs Made In America Acquisition II Corp. appoints new CEO after sponsor repayment issue - Investing.com
CEO exits Drugs Made In America (NASDAQ: DMAA) after affiliate fund withdrawals - Stock Titan
Sponsor overpayment leads to CEO change at Drugs Made In America II (DMII) - Stock Titan
Context Capital Management LLC Buys Shares of 250,000 Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Short Interest Down 21.7% in February - MarketBeat
TRG Latin America Acquisitions Corp. Completes $200 Million Initial Public Offering - The Manila Times
New $200M Nasdaq listing bundles TRG Latin America shares with rights - Stock Titan
TRG Latin America Acquisitions Corp. Announces Pricing of $200 Million Initial Public Offering - The Manila Times
Lake Superior Acquisition Corp.: Dividend historical data and projections - marketscreener.com
New America Acquisition I Corp. Class A Common Stock (NY: NWAX - The Chronicle-Journal
DermTech Stock (DMTK)Quote OTC Markets - marketscreener.com
New America Acquisition I Revamps Board, Appoints New Chair - TipRanks
Drugs Made In America Acquisition (NASDAQ:DMAA) Stock Price Up 0.1% – Here’s Why - Defense World
New America Acquisition I Corp appoints Kyle Wool as board chairman - Investing.com Nigeria
New America Acquisition I Corp. Appoints Kyle Wool as Chairman and Adds Stefan Passantino as Independent Director - The Globe and Mail
New America Acquisition I Corp appoints Kyle Wool as board chairman By Investing.com - Investing.com South Africa
New America Acquisition I Corp Azioni (NWAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.53%
0.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):